Table 1 Patient and transplantation characteristics
All patients | ATG <6 mg/kg | ATG ≥6 mg/kg | p value | ||||
|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | ||
N | 234 | 195 | 39 | ||||
Age, median (range) | 55 | (22–70) | 56 | (22–70) | 55 | (39–65) | 0.976 |
Transplantation period | |||||||
2000–2008 | 122 | 52% | 95 | 48% | 27 | 69% | 0.022 |
2009–2013 | 112 | 48% | 100 | 51% | 12 | 31% | |
Time from diagnosis to Allo-HSCT | |||||||
≤ 6 Months | 138 | 59% | 118 | 60% | 20 | 51% | 0.291 |
> 6 Months | 96 | 41% | 77 | 39% | 19 | 49% | |
Conditioning regimens | |||||||
Flu-Bu | 214 | 91% | 182 | 93% | 32 | 82% | 0.052 |
Other | 20 | 9% | 13 | 7% | 7 | 18% | |
Adverse cytogenetics | |||||||
No | 193 | 82% | 161 | 82% | 32 | 82% | 0.939 |
Yes | 41 | 18% | 34 | 17% | 7 | 18% | |
Follow up, median (range) | 38 | (2–143) | 37 | (2–143) | 41 | (5–123) | 0.403 |
